Organization
Tengion, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Tengion, Inc.
... financial officer. Davis was most recently senior vice president and CFO at Tengion Inc., a regenerative-medicine company that has a manufacturing plant in East Norriton, ...
... Most recently, Mr. Davis served as senior vice president and CFO at Tengion, Inc. He previously worked at Neose Technologies, Inc., where for more than ...
... Tengion's high hopes fall short R emember Tengion? About five years ago, Tengion ...
... Celgene joins an international list of creditors in Tengion's Ch7 bankruptcy filing Back in the summer of 2013, Celgene ($CELG) lined ...
... Tengion came back from the brink multiple times before sliding into bankruptcy Tengion ...
... Triad biotech firm seeks bankruptcy protection Tengion Inc., a Winston-Salem-based firm that's been developing regenerative medicine technologies, is seeking ...
... Auction Auction TARGET COMPANY: 1880911 Tengion Inc. SELLERS: 1880911 Tengion Inc. DEAL VALUE: Undisclosed ANNOUNCEMENT DATE: September 22, ...
... Tengion retains Jefferies to explore potential strategic transactions Tengion retains Jefferies to explore potential strategic transactions Tengion Inc. announced Monday that ...
... Tengion says regenerative kidney treatment trial on track . Tengion, the Winston-Salem biotech company working to commercialize some of the technologies developed ...
... Bankruptcy Warning . COMPANY WITH WARNING: 1880911 Tengion Inc. REFERENCE DATE: March 26, 2014 WARNING SOURCE: Accounting firm WARNING COMPANY: ...
... served as the vice president, general counsel and chief compliance officer for Tengion, Inc., a clinical-stage regenerative medicine company, where he had responsibility for legal ...
... trial initiated in Sweden -- WINSTON-SALEM, N.C., Aug. 14, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business ...
... Million Senior Secured Convertible Note Financing with New and Existing Investors . Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the closing ...
... Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting . Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting. WINSTON-SALEM, N.C., ...
... of 2013 and in U.S. in fourth quarter of 2013 -- . Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business ...
... . Tengion Provides Business Update and Reports First Quarter 2013 Financial Results Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business ...
... Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden. . Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in ...
... Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden . Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in ...
... Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial ...
... Tengion to Present at 25th Annual ROTH Conference . Tengion to Present at 25th Annual ROTH Conference Tengion, Inc. (OTCQB: TNGN), a ...
... Tengion to Present at 25th Annual ROTH Conference . Tengion to Present at 25th Annual ROTH Conference Tengion, Inc. (OTCQB: TNGN), a ...
... Quarter and Full Year 2012 Financial Results on March 18, 2013. . Tengion to Host Conference Call to Provide a Business Update and Report Fourth ...
... Quarter and Full Year 2012 Financial Results on March 18, 2013 . Tengion to Host Conference Call to Provide a Business Update and Report Fourth ...
Want to see the full history on Tengion, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial